All posts by imreal

Ellie Diagnostics and The Veterinary Cooperative (TVC) Announce Partnership


Ellie Diagnostics, a full service veterinary diagnostics laboratory, has announced a strategic partnership with The Veterinary Cooperative (TVC) and it’s 4,000 members around the United States. Through this partnership, Ellie Diagnostics and TVC will empower veterinarians to access high quality diagnostics through its modern technology platform.

“Veterinarians deserve a revamped way to access laboratory testing. Outdated lab contracts and fax results need to be replaced with innovation and the latest technology. This partnership is helping make that a reality for TVCs members,” said Mark DeCourcy, Founder and CEO. Ellie is the fastest growing independent veterinary diagnostics laboratory in the country.

“TVC is proud to partner with organizations that share our passion for the independent veterinary industry, and the individual clinics that keep pets healthy and happy,” said Pablo Lopez, Director of Operations and Marketing at TVC. Serving 4,000 owner hospitals, TVC exists solely to serve the best interests of its owner hospitals. Through this endeavor they partner with companies spanning multiple industries to provide better pricing structures, access to more robust business and marketing training, and foster a sense of community that supports growth and innovation.

About Ellie Diagnostics

Ellie Diagnostics is a privately held veterinary diagnostics company providing innovative laboratory services to independent veterinarians nationwide. They provide a comprehensive menu of lab services, client-friendly results, competitive pricing and a contract-free business philosophy. To learn more about Ellie Diagnostics, please visit: http://www.elliediagnostics.com.

About The Veterinary Cooperative

TVC is the largest veterinarian-owned purchasing cooperative in the United States. Established by four veterinarians, TVC utilizes their collective size to level the field in pricing, marketing and business strategies between independent practices and the growing number of corporate hospitals, big box stores, online pharmacies and providers that are encroaching on the independent animal hospital’s ability to be profitable. To learn more about The Veterinary Cooperative, please visit: http://www.tvc.coop.

Share article on social media or email:

Navigating Cancer extends digital health leadership with advanced remote monitoring solution


Health Tracker Remote Monitoring solution

As the COVID-19 pandemic accelerates the adoption of digital health technology for vulnerable cancer patients, Health Tracker is a critical tool for cancer care.

At Navigating Cancer we’re passionate about delivering solutions that advance patient care and safety for health care workers and patients alike. Health Tracker is a great example of that.

Navigating Cancer, the developer of the most broadly deployed patient relationship management (PRM) platform in oncology, today announces the next era of electronic patient-reported outcomes (ePRO) with the release of its newest Health Tracker Remote Monitoring solution.

As the COVID-19 pandemic accelerates the adoption of digital health technology for vulnerable cancer patients, remote monitoring and telehealth are emerging as critical tools for providers to stay connected, deliver proactive care, and help patients avoid unnecessary hospital visits.

An established innovator in oncology patient solutions, Navigating Cancer first released Health Tracker in 2015 to enable care teams to provide high response assistance for symptom management and monitor compliance for oral therapies. Today the company launched its redesigned Health Tracker program making it even easier for patients to stay connected to their care team – regardless of their level of technological literacy. In an April 2020 survey on Health Tracker, 93% of patients reported that Health Tracker was a useful tool to get their side effects addressed. One patient commented, “I feel very cared for and it’s so easy!”

A landmark study published in 2017 found that ePROs extended patients’ lives and also reduced the cost of care including a 7% reduction in emergency department visits. To ensure all patients have access during treatment, Health Tracker is designed to be easy-to-use and accessible by a wide array of patients. Patients can participate via smartphone, tablet, laptop or desktop computer as well as receive reminders via text message or email. Health Tracker 2.0 also features “Clinic Collect” which enables the care team to schedule and complete patient check-ins by phone on behalf of participating patients. These features eliminate many barriers that other ePRO tools face in the market.

Rhonda Hastings, RN OCN, Nursing Manager at Minnesota Oncology said, “We work to enroll all patients starting therapy, to treat their oncology diagnosis in the program and have been very pleased with the high participation rate and the added insights we are gaining about our patients when we can’t be with them.” Minnesota Oncology launched Health Tracker in February and has seen steady participation rates of over 75% of enrolled patients.

In addition to versatile options for patient participation, the biggest challenge to widespread adoption of ePRO tools in clinical practice is integrating them into existing workflows. Health Tracker integrates seamlessly with Navigating Cancer’s Care Management and triage solution which is currently utilized by over 1,800 providers across the US. Additionally, new features enable patients to request a call or a medication refill with a click of button, making it easier for patients to receive support. This integrated workflow enables cancer care providers to easily scale an ePRO program within the practice’s already established triage and symptom management operations.

“Health Tracker 2.0 takes into account utilization metrics, practice feedback, and patient input to create a streamlined solution for remote symptom management and oral compliance,” said Chief Product Officer Michael Graff. “At Navigating Cancer we’re passionate about delivering solutions that advance patient care and safety for health care workers and patients alike. Health Tracker is a great example of that.”

Navigating Cancer scientific medical advisor and leading PRO researcher, Dr. Ethan Basch said, “Navigating Cancer has been a pioneer in solutions that allow ePROs to be integrated into clinical workflow. I’m looking forward to seeing the impact of their new approach on patient care and satisfaction.”

About Navigating Cancer

Navigating Cancer is an oncology digital health company focused on improving the lives of cancer patients and those who care for them. Our comprehensive Navigating Care platform helps providers boost their financial performance, enables more effective remote care management, and delivers a better patient experience while providing valuable insights for oncology innovation. With over 1,800 providers using the Navigating Care platform to care for over 1 million patients, it is the most broadly deployed oncology patient management solution in the US.

For more information, please visit http://www.navigatingcancer.com or follow Navigating Cancer on Twitter @navcancer.

Share article on social media or email:

Nearly a Third of U.S. Consumers Perceive No Communication as Bad News During COVID-19 Pandemic


In the midst of COVID-19, consumer sentiments have drastically evolved as they’ve become more conservative with spending and more selective on what and where to purchase. The global study, Don’t Stop, The Future is Now, released by Media Frenzy Global in partnership with Arlington Research, revealed just under a third (31%) of U.S. consumers worry businesses who have failed to share any company news or content during the pandemic are in financial trouble and because of this, they likely wouldn’t spend with them.

Conducted online between late April and mid-May, 13,000 respondents across generations from 14 countries were surveyed, including 2,500 from the United States. In addition to shifts in consumer sentiment, the data revealed interesting trends being experienced across the country:

● Just under half of U.S. respondents (47%) are desperate to hear about non-COVID-19 news;

● 50% of U.S. respondents surveyed agree they spend more time-consuming content than ever before

● 45% of those surveyed agree they want to be inspired by brands so they can be hopeful about the future, which ultimately inspires them to spend money with these brands when this is all over;

● 38% of Americans said their perceptions of businesses have changed;

● More than a third of respondents are concerned about their job security if their company (or employer) has gone quiet; the U.S. is among countries where agreement is highest at 35%.

“It’s undeniable without a clear communication strategy, you risk consumers forming their own conclusions—and those conclusions might not even be right. Your business may be faring the storm, but if your staff and customers aren’t aware and may be reluctant to place that next order for fear you might not be able to fulfill it. Likewise, if we want to restore faith in our economies, we must keep employees up to date on company news, changes and the future,” says Sarah Tourville, CEO and Founder at Media Frenzy Global.

Unsurprisingly, 50% of U.S. respondents surveyed said their consumption of content increased during the pandemic when compared to before. Much of this can undoubtedly be attributed to lockdowns, with people spending the majority of their time at home surfing the internet.

The research also sheds light on topics consumers are craving. Nearly half of all surveyed (47%) agree they want to hear and read news unrelated to the pandemic, with just 20% in disagreement. This desire for non-COVID-19 news is felt across generations, ranging from 51% millennials to 43% of the ‘silent generation’ (those aged in their 70s and 80s).

Consumers have also indicated when businesses are communicating with them; they want to feel encouraged and heartened by their message. Over a third (35%) of those surveyed stated during the crisis, brands that inspire them and give them hope are the ones they want to spend money with in the future. This is especially true for those dwelling in larger metropolitan cities across the U.S., compared to more rural regions.

“People want news and want to be inspired. The majority of respondents who took part in our survey, of which there were 13,000 consumers from 14 countries across the world, told us how well a company responds to the coronavirus crisis will have a huge bearing on the likelihood of buying from them in the future. Do not underestimate the ‘power of now.’ Now is not the time to go stop your communications – the beginning is always today,” concludes Paul Stallard, Managing Director at Arlington Research.

“As a company providing a full range of services to support major retailers’ and brands’ online business, we have experienced a significant uptick during the pandemic. Not only are people shopping and buying more online, but they are getting a more direct experience with the brands they buy. This research indicates that going silent is breaking an important connection between companies and their customers. There’s a clear opportunity for companies to be generous in their communications with customers to improve brand loyalty now and in the future,” says Michael Wright, VP of Marketing & Solutions at PFS.

Further findings from the survey are available in full, HERE.

To schedule an interview with spokespeople from Media Frenzy Global and Arlington Research, please contact Matthew Kaiserman at Media Frenzy Global at matthew@mediafrenzyglobal.com or (678) 943-7408.

About Media Frenzy Global

An award-winning agency, Media Frenzy Global (MFG), grows total company value for technology companies by increasing market awareness and connecting that to revenue. MFG is the only internationally-focused boutique PR and Marketing agency in Atlanta whose sole focus is to build innovative and disruptive brands across continents. Its international cross-border expertise, diverse team, multi-award-winning campaigns, and 5-star customer testimonials make MFG a leading choice for brands seeking to tell progressive stories that connect with a multicultural and multigenerational audience. For more information on Media Frenzy Global, visit http://www.mediafrenzyglobal.com.

About Arlington Research

Arlington Research is a full-service independent market research agency. We provide clients from around the world with robust data via quantitative research, in-depth exploration via qualitative research, and audits on what’s out there already via desk research. All our team are director level and focused on providing intelligent analysis and creative insight that help our clients bring their story to life. Our director-level team will design your research from sample design to final reporting. Each piece of research is reliable, robust, delivered with a quick turnaround, and analyzed to ensure the research creates maximum impact. Our scope of work is broad, and we run research for leading brands and organizations from many different sectors. We are experienced in researching hard-to-reach audiences and markets and we would love to help bring your story to life. arlingtonresearch.global

For Media Inquiries:

Matthew Kaiserman, Media Frenzy Global

matthew@mediafrenzyglobal.com

(678) 943-7408

Share article on social media or email:

Olaris CEO Elected to Personalized Medicine Coalition Board of Directors


Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced that The Personalized Medicine Coalition (PMC) has elected Olaris CEO and Founder Dr. Elizabeth O’Day to serve a three-year term on the PMC Board of Directors.

Founded in 2004, The Personalized Medicine Coalition represents innovators, scientists, patients, providers and payers, to promote the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and the health system. Believing that paradigm shifts, especially in medicine, do not happen just because the science and new technologies suggest they should, the Coalition supports investment in and adoption of personalized medicine through education, advocacy, and evidence development.

“Over the last decade, the growth of the personalized medicine industry has demonstrated that tailoring treatment and prevention plans to each individual patient can dramatically improve health outcomes,” said Dr. Elizabeth O’Day. “I’ve dedicated my life to the advancement of personalized medicine, and during my term on the PMC Board of Directors, I look forward to collaborating with stakeholders across academia, industry, and government to work towards a future where access to personalized medicine is ubiquitous.”

Dr. O’Day brings an extensive personalized medicine background in both academia and industry to PMC’s board of directors. She is the CEO and Founder of Olaris, Inc., a precision medicine company that has developed a metabolomics platform and machine learning algorithms to determine which patients will benefit from a specific drug. Dr. O’Day is also the co-chair of the World Economic Forum’s Global Future Council on Biotechnology, and a member of Scientific American’s Steering Committee for the publication’s annual “Top 10 Emerging Technologies.” She received her PhD from Harvard University, where she was a National Science Fellow, an MPhil in Chemistry from the University of Cambridge where she was a Churchill Fellow and a BS in Biochemistry from Boston College where she was a Finnegan Award winner, Beckman Scholar, Goldwater Scholar and graduated summa cum laude.

In the announcement of Dr. O’Day and Tempus SVP of External Affairs Lauren Silvus, PMC Board Chair Jay G. Wohlgemuth, M.D., Chief Medical Officer, Senior Vice President, Quest Diagnostics, said, “Both of these new board members are collaborative leaders who are committed to working across sectors to advance personalized medicine for the benefit of patients and health systems. I am confident that both Liz and Lauren will help the Coalition in its efforts to promote the understanding and adoption of personalized medicine across all sectors.”

To learn more about the Personalized Medicine Coalition, visit http://www.personalizedmedicinecoalition.org.

About Olaris

Olaris is working to fundamentally change how diseases are treated. The company’s metabolomics platform and machine learning algorithms produce Biomarkers of Response (BoR), which removes the guesswork when treating an individual patient’s disease. To learn more, visit http://www.olarisbor.com.

Share article on social media or email:

Children’s Miracle Network Hospitals Announce Speedway as Corporate Partner of the Year


Speedway saw a remarkable 25% fundraising increase in 2019 to $11.8 million thanks to some innovative campaigns like the coloring book, growth in their annual golf tournament and the launch of the pin pad donation ask. –Teri Nestel, interim president and CEO of Children’s Miracle Network Hospitals

Children’s Miracle Network Hospitals (CMN Hospitals) recently recognized Speedway LLC (Speedway) for its outstanding partnership and commitment to supporting the network of member children’s hospitals by naming the company as the Corporate Partner of the Year for 2019.

The Corporate Partner of the Year award recognizes an outstanding organization that has demonstrated extraordinary commitment to CMN Hospitals or Foundations through innovative fundraising and awareness initiatives.

“Speedway really is fueling miracles,” said Teri Nestel, interim president and CEO of Children’s Miracle Network Hospitals. “The company saw a remarkable 25% fundraising increase in 2019 to $11.8 million thanks to some innovative campaigns like the coloring book, growth in their annual golf tournament and the launch of the pin pad donation ask.”

The majority of funds come year-round from customers, business partners and employees who contribute via a new donation prompt while checking out or in donation canisters at each store.

Speedway’s recent expansion to the West Coast allowed them to support 17 new CMN Hospitals, and now broadens the reach of their impact to a total of 80 CMN Hospitals across America.

Speedway also celebrated a new fundraising record of $2.7 million at their annual Speedway Miracle Tournament—one of the largest golf fundraising tournaments held to benefit Children’s Miracle Network Hospitals. Each year, Speedway organizes the Miracle Children Program, where patient families from locally supported hospitals are able to share their stories to raise awareness of the ongoing needs of children’s hospitals and how changing kids’ health can positively change the future of their communities. The firsthand experiences bring a personal touch to the cause and highlights the importance of donations to fund critical treatments and services.

Speedway’s partnership with Children’s Miracle Network Hospitals began in 1991 and has since raised more than $121 million for the children’s charity through various fundraising activities.

Children’s Miracle Network Hospitals raises funds and awareness for 170-member hospitals that treat more than 10 million kids each year. A donation made at a local Speedway directly supports the member hospital serving that community.

About Speedway LLC

Speedway LLC (Speedway) is the nation’s second largest company-owned and -operated convenience store chain with nearly 3,900 retail convenience stores across the United States. Headquartered in Enon, Ohio, Speedway is a subsidiary of Marathon Petroleum Corporation (NYSE: MPC). For more information, visit http://www.speedway.com.

About Children’s Miracle Network Hospitals

Children’s Miracle Network Hospitals® raises funds and awareness for 170 member hospitals that provide 32 million treatments each year to kids across the U.S. and Canada. Donations stay local to fund critical treatments and healthcare services, pediatric medical equipment and charitable care. Since 1983, Children’s Miracle Network Hospitals has raised more than $7 billion, most of it $1 at a time through the charity’s Miracle Balloon icon. Its various fundraising partners and programs support the nonprofit’s mission to save and improve the lives of as many children as possible. Find out why children’s hospitals need community support, and learn about your member hospital, at CMNHospitals.org and facebook.com/CMNHospitals.

Contact:

Marna Berlekamp, Marathon Petroleum Corporation

meberlekamp@marathonpetroleum.com

419-421-3278

Heather King, Children’s Miracle Network Hospitals

hking@cmnhospitals.org

801-214-7400

Share article on social media or email:

Can Complementary Therapies Help Breast Cancer Patients?


Dr. Constance Chen

Complementary therapies may help women with the effects of mainstream medicine and its treatments. With the approval of their doctors, some women have found benefits from therapies such as acupuncture; aromatherapy; exercise, including yoga and tai chi; and meditation and relaxation techniques.

Breast cancer, the most commonly occurring cancer in women, is traditionally treated with a combination of surgery, radiation, and chemotherapy. In seeking to maximize the benefits of these treatments and minimize their often-debilitating side effects, many women consider adding various complementary therapies to their treatment regimens.

“Complementary therapies may help women with the effects of mainstream medicine and its treatments,” says plastic surgeon and breast specialist Dr. Constance M. Chen. “With the approval of their doctors, some women have found benefits from therapies such as acupuncture; aromatherapy; exercise, including yoga and tai chi; and meditation and relaxation techniques. These are referred to as ‘complementary’ rather than ‘alternative’ therapies, since they work in concert with traditional treatments; they don’t replace them.”

Safety first

In some women, integrating complementary therapies with standard treatment can help relieve common signs and symptoms such as anxiety, fatigue, nausea and vomiting, pain, difficulty sleeping, and stress. Although not all medical professionals are supportive, it may be useful to bring your doctor into your plans before undertaking a complementary regimen. “Standard treatments have been through a rigorous scientific process of testing and clinical trials to determine their safety and effectiveness,” she says. “The same isn’t always true of alternative therapies. In particular, some herbal supplements interact with cancer drugs in ways that can make traditional medication less effective. The ‘natural’ label is no guarantee of safety. The same is true of large doses of some vitamins. Although many traditional doctors are not well educated in alternative therapies, you can try asking your doctor for advice on safety and on the best strategy for you.”

Which therapies are safe and effective?

Acupuncture has been used in Chinese medicine for thousands of years. A practitioner applies hair-thin, sterilized needles to specific points on the skin and moves them gently to stimulate the nervous system. The strongest evidence for acupuncture as an adjunct to cancer treatment has been found in clinical trials that demonstrated effectiveness in reducing the nausea and vomiting caused by chemotherapy drugs or by anesthesia used in surgery. It has also been found effective in limited studies in reducing pain for some cancer patients and in reducing the hot flashes suffered by women undergoing hormone therapy. There is some evidence that acupuncture may help relieve fatigue and resolve problems sleeping. The FDA has approved the use of acupuncture by licensed practitioners. Many states regulate the practice; you should do your own research to find a certified practitioner.

Aromatherapy is the use of essential oils from plants to improve physical, mental, and spiritual well-being. Essential oils are extracted from the fragrant part of the plant, which is often found under the surface of leaves, bark, or peel. The fragrance is released when the plant is crushed or a special steam process is used. Essential oils used in aromatherapy include those from geranium, lavender, tea tree, lemon, ginger, cedarwood, bergamot, and Roman chamomile. Each has a different chemical makeup that affects how it smells, how it is absorbed, and how it affects the body. Essential oils are most often inhaled indirectly via a diffuser that distributes the oil in the air. They may also be diluted and massaged into the skin. While studies have shown mixed results, some have shown benefits to cancer patients in instilling a feeling of calm, relieving anxiety, improving sleep, and reducing nausea and pain. A study of breast cancer patients found inhalation of ginger oil to have some effect in reducing acute nausea. Aromatherapy is generally considered safe when used as directed, though the oils can cause an allergic reaction in some women when applied directly to the skin and lavender and tea tree oils have estrogen-like effects that can be detrimental in some cases.

Exercise has been shown to improve outcomes for cancer patients and improve quality of life. It can relieve stress and fatigue and improve sleep. An exercise program should be started slowly, building up gradually to thirty minutes most days of the week. Tai chi is a form of exercise that uses slow, gentle movements and deep breathing. It is generally safe, doesn’t require physical strength, and can relieve stress. Yoga comes in many variations, some of which require considerable bending, twisting, and stretching along with deep breathing. It’s important to avoid poses that cause discomfort. Many cancer patients find yoga relieves stress and fatigue and improves sleep.

Meditation is a method of deep concentration on a single thought, often combined with deep breathing and relaxation techniques that calm the mind and relax the muscles. Many people who practice meditation do so once or twice a day, often starting with the help of an instructor. These practices are generally credited with relieving anxiety and stress.

“These therapies bring relief to many breast cancer patients,” says Dr. Chen. “You may find benefit from the therapy itself and also from the psychological support and conviction that you are doing everything possible to enhance the success of your treatment and to sustain the best possible quality of life as you heal.”

Constance M. Chen, MD, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. She is Clinical Assistant Professor of Surgery (Plastic Surgery) at Weill Cornell Medical College and Clinical Assistant Professor of Surgery (Plastic Surgery) at Tulane University School of Medicine. http://www.constancechenmd.com

Share article on social media or email:

Net Health Selects Updox Telehealth to Serve Outpatient Facilities and Therapy Services in Skilled Nursing Facilities and Home Health


News Image

Updox shares Net Health’s vision of powerful solutions that drive patient care and help providers have a greater impact on outcomes.

Updox, the only place to manage healthcare communications across both in-person and virtual care, today announced a partnership with Net Health, a premier provider of cloud-based Electronic Health Record (EHR) software for specialized care settings. Net Health serves more than 14,000 physical therapy, wound care, occupational medicine, employee health and hospice facilities, as well as 98 percent of large hospital networks in the US. Net Health will integrate the Updox platform with its classic ReDoc® software, Agility® software, therapy solution used in skilled nursing facilities and home health therapy software to support clients in the delivery of telehealth, video chat, secure text and SMS text services to their patients.

“Updox shares Net Health’s vision of powerful solutions that drive patient care and help providers have a greater impact on outcomes,” says Net Health CEO Josh Pickus. “Telehealth gives our clients the flexibility to incorporate virtual visits into their engagement workflow to ensure that care continues during this pandemic. The Updox solution is HIPAA-compliant and exceptionally easy to use for both patients and providers—we’re confident we’re offering a solution that our clients can get up and running quickly.”

Updox supports safe, effective ongoing treatment and care, while reducing potential coronavirus exposure to protect both staff and patients. The Updox solution was created to be as easy as making a phone call, and requires no special equipment or apps to download, just internet access. Updox facilitates up to 45,000 telehealth visits per day between patients and their healthcare providers.

“We’re proud to partner with Net Health to ensure healthcare providers can safely and securely offer remote care for patients to minimize the spread of COVID-19,” says Michael Morgan, chief executive officer, Updox. “During this time of crisis, quickly implementing comprehensive and secure telehealth services ensures that healthcare services continue in ways that are safe, secure and personal. Beyond the pandemic, we know healthcare will continue to see increased demand for virtual care, driven by patient preference for convenient, consistent and accessible connections with their providers of choice.”

In a recent Updox survey, 42 percent of Americans said they have used telehealth services since the pandemic began and 82 percent of that group said they love/like telehealth services. When asked about their preferences for using telehealth following COVID-19, 51% of respondents said convenience was most important to them, and 49% said that they wanted to be able to choose their provider rather than be assigned a healthcare professional for telehealth services.

About Updox

The only place to manage healthcare communications across both in-person and virtual care, Updox offers one consolidated inbox for healthcare providers to manage patient journey products and office productivity. Updox provides a broad set of capabilities for virtual health, patient engagement, and paperless office efficiency that work together in a secure, easy-to-use collaboration platform. Updox customers also benefit from an engaged user community for benchmarking, idea exchange and networking. Learn how we simplify the business of healthcare. Visit http://www.updox.com or follow the company on Twitter, LinkedIn and Facebook.

About Net Health

Net Health provides cloud-based software for specialty medical providers across the continuum of healthcare—from hospital to home. Net Health’s interoperable EHRs deliver end-to-end solutions that ensure compliance, improve outcomes, empower providers and inspire care. The company serves over 14,000 facilities, including 98 percent of the largest hospital chains, two-thirds of skilled nursing facilities and many leading hospice organizations and private practices. Net Health is a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners. http://www.nethealth.com

Share article on social media or email:



PWCampbell Announces Transition of Ownership and Management As Part of Its Strategic, Long-Term Succession Plan


One of the greatest responsibilities we have as a Board and management team is to prepare the next generation so that the company can continue to thrive.

PWCampbell, a fourth-generation retail services and design-build firm, announces key ownership and management changes that have been enacted as part of the Company’s long-term succession plan. This is only the third time in 110 years that a generational transition in ownership has been made involving the company.

Carlin Campbell, Erin Campbell and Amanda Campbell Caliendo have transitioned from Vice Presidents to Principals, and will continue to increase their ownership in the firm.

As the Company continues to grow and diversify, Carlin Campbell will be Chief Operating Officer and be responsible for managing the production area for the firm including construction, architecture and corporate technology. Erin Campbell will assume new responsibilities in the Company’s human resources department and will continue her activities in corporate development and client relations. Amanda Campbell Caliendo is now responsible for managing interior designs, furniture and design-build branding services.

As part of the plan, James Caliendo has transitioned from President and Chief Operating Officer to President and Chief Executive Officer. He will continue in his role in overall executive management for the firm with an emphasis on business development, corporate planning, marketing and finance.

As Principal James Campbell transitions into retirement while remaining on the Board of directors, his brother and Principal John Campbell will remain in his current position with a focus on corporate and business development moving away from day-to-day operations. It was under their leadership and stewardship over the past half a century, as third-generation owners, where the firm drastically grew its client base by focusing on quality, client satisfaction and diversification of the business.

The PWCampbell Board of Directors now includes James Campbell, John Campbell, James Caliendo, Carlin Campbell, Erin Campbell and Amanda Campbell Caliendo.

According to President and CEO James Caliendo, “We have been working on our long-term succession plan involving this shift to fourth-generation ownership for the past five years. These promotions are all well-earned and have been a work in progress. Carlin, Erin and Amanda have been major contributors to our success and growth and will be excellent leaders as we continue to build the future of the firm. They will have a long-tenured group of managers working alongside them.”

In addition to the announcement of the new owners and shifting of responsibilities, two other senior managers have been promoted.

Dean Giordano has been promoted from Senior Vice President to Executive Vice President, Design and Construction, where he is responsible for architectural, preconstruction and construction services. Kevin Poirot has been promoted from Senior Vice President to Executive Vice President, Branded Environments, where he is responsible for retail branding and client technology solutions.

Principal John Campbell said, “One of the greatest responsibilities we have as a Board and management team is to prepare the next generation so that the company can continue to thrive. Developing the new leadership, while those of us with decades of experience are still here, is a critical component of our succession plan. We look forward to continuing our client successes while upholding the legacy of excellence started by our founders.”

Being family-owned and managed has been in the DNA of PWCampbell since it was founded in 1910 by Phillip W. Campbell. His sons James L. Campbell Sr. and John C. Campbell then ran the firm and represented the second generation. After that, the sons of James L. Campbell Sr.—current Principals James and John Campbell—continued to run the company and are now in the process of passing the baton of leadership to Jim’s daughter Erin and John’s children Carlin and Amanda.

PWCampbell is a retail services and design-build firm, with over 110 years of experience. We are dedicated to serving our clients by providing the planning, design and construction expertise they seek to optimize their building and marketing efforts. With our strength in the design-build area, we have evolved into a fourth generation, full-service professional organization concentrating our efforts in the financial, commercial and residential industries.

Share article on social media or email:

The Bridge Club Turns Small Talk Between Pet Owners and Veterinarians into a Big Conversation


The Bridge Club Pets is a virtual community for pet parents. A place to come for informed insight and guidance from veterinary professionals whose everyday focus is the health and well-being of pets.

The Bridge Club inspires professional and personal growth and creates connections. It’s a “Ted-Talks meets LinkedIn + book club” concept that brings people together in an atmosphere of trust and camaraderie.

Today, more than 40 percent of all pet owners reach out to Google or one of the thousands of pet-related Facebook Groups before reaching out to their own veterinarians. After more than three years of successfully hosting conversations with the veterinary profession, The Bridge Club launches The Bridge Club Pets (TBC Pets), a virtual community where pet owners can gather in a casual conversation to gain informed insight and guidance directly from veterinary professionals.

Bridging conversations to the pet owner was not too big of a stretch for The Bridge Club. “In virtually every conversation we have had with more than 25,000 veterinary professionals, it always comes up that they wish the pet owner knew this, or did that, to help with the health and well-being of their pets,” says Catherine Haskins of The Bridge Club. “What we are finding is that pet owners WANT to have these conversations and WANT to know what they need to do from real professionals who care.”

Haskins added that the goal of TBC Pets is to further elevate the view of veterinarians and veterinary technicians. Originally, TBC Pets was scheduled to launch later this Fall but was expedited with the support of Zoetis Petcare to help pet owners address their growing concerns about safety and transmission during the current quarantine.

The conversations take place on Zoom and are streamed on Facebook Live and Instagram. All pet owners register in advance and follow the same Bridge Club “rules” to turn on their cameras and bring a beverage to toast the conversation. Pet owners are able to pose questions to the special guest in the chat function. TBC Pets has partnered with whiskerDocs to have certified veterinary technicians in the conversation with pet owners to help provide resources and answer their general questions. All pet owners are encouraged to see their veterinarians.

“We are excited to be a part of the community that The Bridge Club is building,” says Deb Leon, CEO of whiskerDocs, whose veterinary team has been answering pet questions during TBC’s virtual conversations. “As more and more families bring pets into their homes, they are looking for reliable resources to help them do their best at caring for their pet family members. Our whiskerDocs family of over 4 million pets has taught us how important it is for pet owners to have instant access to pet expertise and support when and how they need it.”

To date TBC Pets has already had more than 5,000 pet owners register for their conversations that include: Caring for Your Pet while Sheltering with Dr. Ernie Ward, Telemedicine for Pets with Dr. Audrey Wystrach, Is Being Home Stressing Your Pet with Dr. Amy Pike, Is My Pet Gaining the Quarantine Pounds Again with Dr. Ward and How to Care for Your Aging Pet with Dr. Shea Cox. The feedback has been overwhelming with immediate survey results indicating 92 percent would attend a second session and 8 percent are considering it. Already, The Bridge Club has seen up to 25 percent repeat attendees.

All conversations are free to pet owners. To learn more about what The Bridge Club Pets has scheduled next, visit http://www.thebridgeclubpets.com.

About The Bridge Club

The Bridge Club is the first video-based, professional community created to connect the industry’s best in just 25 minutes. The Bridge Club inspires professional and personal growth and creates connections. It’s a “Ted-Talks meets LinkedIn + book club” concept that brings people together in an atmosphere of trust and camaraderie. To learn more, visit http://www.thebridgeclub.com and http://www.thebridgeclubpets.com.

Share article on social media or email:

Leading CBD Brands Collaborate to Sponsor Observational Research Aimed at Answering FDA’s Safety Concerns


“Continued data collection is vital for all parties involved. As a group, we’ve engaged the FDA on study protocol and partnered with academic experts. We are [all] committed to consumer safety. This data will help pave the path forward for our industry.” – Chase Terwilliger, CEO of CBDistillery.

ValidCare announced today that Boulder Botanical & Bioscience Labs, CBDistillery, CBD American Shaman, Charlotte’s Web, Columbia Care, HempFusion, and Kannaway will participate in an industry-wide study measuring the effects on the liver from daily use of full spectrum hemp derived CBD and CBD isolate by healthy adults. The companies are answering FDA’s repeated request, including the agency’s March 5, 2020 report to Congress for science-based data so it can confidently determine the appropriate regulatory path(s) for hemp derived CBD products.

“After inviting and screening over 100 brands to participate in this water-shed research, seven companies have chosen to demonstrate real leadership, collaboration and commitment to consumer safety,” said Patrick McCarthy, CEO of ValidCare. “With over 3,500 brands vying for market share, these brands put a premium on science, data and consumer safety over just marketing and revenues. ValidCare is proud to sponsor this research and help answer important questions for the industry, while preserving intellectual property and rights to re-use this data with FDA for individual product submissions at a later date.”

Regulation of hemp derived CBD products by FDA has been stalled since the passage of the 2018 Farm Act despite thousands of brands being available for purchase. “The lack of regulatory clarity creates risk for the industry and the American consumer,” said Jason Mitchell, CEO of HempFusion. “We realized we have a choice to be part of the process and so we have opted to do so.”

The first step of the process is to collect and provide “real world evidence” from healthy American adults who have consumed oral CBD products for at least 60 days. Measures include reported product experiences and a blood sample to understand how the consumer’s liver reacts. “Charlotte’s Web invests in precision science through our CW Labs and also through important research studies such as this ValidCare study because this research will provide much needed data,” said Tim Orr, Vice President of Innovation at Charlotte’s Web. “By being both science and data-driven we can secure long term consumer trust, while also addressing the FDA’s safety concerns with CBD products.”

The observational study was designed with significant input from FDA, the brands and third-party principal investigators (Keith Aqua, MD and Jeffrey Lombardo PharmD, BCOP), respected and peer reviewed medical doctors and PhDs in Biostatistics. The study is planned to start in early Q3, 2020 and is expected to be completed by year end. The design calls for participation by a minimum of 700 consumers. This data will be combined with personal history, blood tests and product data to provide investigators with the opportunity to understand multiple variables across populations, products and lifestyles.

“At this time, the FDA continues to assert that, without additional data from qualified experts, they’re unable to develop an appropriate regulatory scheme specific to CBD,” said Chase Terwilliger, CEO of CBDistillery. “That’s why continued data collection is vital for all parties involved, and why, as a group, we’ve engaged the FDA on study protocol and partnered with academic experts. We are confident in our products and processes and are committed to consumer safety. This data will help pave the path forward for our industry.”

“We are pleased to announce our participation in this study as we continue to provide the FDA with the research needed to move the industry forward,” said Rosemary Mazanet, MD PhD, and Chief Science Officer, Columbia Care Inc. “We hope to reveal real world evidence that supports daily CBD use in healthy adults and with the advancement of this study, we will better equip the cannabis community about its health benefits.”

                                                                                                         # # #

About ValidCare

ValidCare, LLC provides clinical research outsourcing (CRO) and consumer intelligence solutions for the consumer packaged goods (CPG) and life sciences industries. ValidCare’s proprietary platform supports virtual research powered by real world evidence (RWE) including self-reported consumer data to deliver insights that help improve research, regulations, product development and consumer health. For more information, visit http://www.validcare.com or call 844-825-4322.

Share article on social media or email: